[Construction of apoptosis-stimulating of p53 protein 2 gene knockout mice and its effect on diethylnitrosamine-induced liver cancer]
Related Experiment Video
Updated: Dec 5, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
1Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Abstract:
Objective: To construct apoptosis-stimulating of p53 protein 2 (ASPP2) gene knockout mice using diethylnitrosamine (DEN)-induced liver cancer model to study the biological functions of ASPP2. Methods: The sgRNA oligonucleotides were constructed, and ASPP2 knockout mice were prepared with the CRISPR/Cas9 system. PCR and sequencing methods were used to identify the genotypes of F0 and F1 generations and their progeny. DEN was used to induce ASPP2+/- mice to establish liver cancer model. Results: PCR and sequencing results showed that ASPP2 gene was successfully knocked out in F0 generation mice. The genotype of F1 generation mice was accorded with ASPP2+/- and had obtained stable heredity. The success rate of DEN-induced liver cancer model (7/8 and 3 / 8) of ASPP2 + /-mice obtained by self-hybridization of F1 generation was significantly higher than that of wild-type mice. Conclusion: ASPP2 knockout mice were successfully constructed based on the CRISPR/Cas9 system. The success rate of DEN-induced liver cancer model of ASPP2 knockout mice was significantly higher than that of the wild-type mice.
Insights
Apoptosis-stimulating of p53 protein 2 (ASPP2) knockout mice were successfully created using CRISPR/Cas9. These ASPP2 knockout mice showed a significantly higher success rate in developing liver cancer models when induced with diethylnitrosamine (DEN).
Area of Science:
- Genetics and Molecular Biology
- Oncology
- Animal Models
Background:
- The tumor suppressor function of ASPP2 is crucial in various cancers.
- Understanding ASPP2's role requires robust experimental models.
- Existing models may not fully capture ASPP2's in vivo functions.
Purpose of the Study:
- To generate ASPP2 gene knockout mice.
- To utilize a diethylnitrosamine (DEN)-induced liver cancer model.
- To investigate the biological functions of ASPP2 in liver carcinogenesis.
Main Methods:
- CRISPR/Cas9 gene editing technology was employed to create ASPP2 knockout mice.
- Single guide RNA (sgRNA) oligonucleotides were synthesized for gene targeting.
- Polymerase Chain Reaction (PCR) and sequencing confirmed ASPP2 gene knockout and heredity.
- Diethylnitrosamine (DEN) was administered to induce liver cancer in ASPP2+/- mice and wild-type controls.
Main Results:
- Successful generation of ASPP2 knockout mice (F0 and F1 generations) confirmed by PCR and sequencing.
- Stable inheritance of the ASPP2+/- genotype in the F1 generation.
- Significantly higher incidence of DEN-induced liver cancer in ASPP2+/- mice (7/8 and 3/8) compared to wild-type littermates.
Conclusions:
- The CRISPR/Cas9 system effectively produced ASPP2 knockout mice.
- ASPP2 deficiency enhances susceptibility to DEN-induced liver cancer.
- These knockout mice serve as a valuable model for studying ASPP2's role in liver cancer.
Related Concept Videos
In-vitro Mutagenesis
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

